124 related articles for article (PubMed ID: 37820591)
1. Correlation between Bilirubin Elimination with the Cytokine Adsorber CytoSorb® and Mortality in Critically Ill Patients with Hyperbilirubinemia.
Gräfe C; Paal M; Winkels M; Irlbeck M; Liebchen U; Scharf C
Blood Purif; 2023; 52(11-12):849-856. PubMed ID: 37820591
[TBL] [Abstract][Full Text] [Related]
2. Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: a pilot study.
Scharf C; Liebchen U; Paal M; Becker-Pennrich A; Irlbeck M; Zoller M; Schroeder I
Sci Rep; 2021 May; 11(1):10190. PubMed ID: 33986443
[TBL] [Abstract][Full Text] [Related]
3. Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis.
Scharf C; Liebchen U; Paal M; Irlbeck M; Zoller M; Schroeder I
Crit Care; 2021 Jan; 25(1):41. PubMed ID: 33509234
[TBL] [Abstract][Full Text] [Related]
4. Hemoadsorption in isolated conjugated hyperbilirubinemia after extracorporeal membrane oxygenation support. Cholestasis of sepsis: A case report and review of the literature on differential causes of jaundice in ICU patient.
Piwowarczyk P; Kutnik P; Potręć-Studzińska B; Sysiak-Sławecka J; Rypulak E; Borys M; Czczuwar M
Int J Artif Organs; 2019 May; 42(5):263-268. PubMed ID: 30919732
[TBL] [Abstract][Full Text] [Related]
5. Increased mortality in critically ill patients with mild or moderate hyperbilirubinemia.
Pierrakos C; Velissaris D; Felleiter P; Antonelli M; Vanhems P; Sakr Y; Vincent JL;
J Crit Care; 2017 Aug; 40():31-35. PubMed ID: 28314169
[TBL] [Abstract][Full Text] [Related]
6. Blood Purification With CytoSorb in Critically Ill Patients: Single-Center Preliminary Experience.
Calabrò MG; Febres D; Recca G; Lembo R; Fominskiy E; Scandroglio AM; Zangrillo A; Pappalardo F
Artif Organs; 2019 Feb; 43(2):189-194. PubMed ID: 30156308
[TBL] [Abstract][Full Text] [Related]
7. Evaluating mortality and recovery of extreme hyperbilirubinemia in critically ill patients by phasing the peak bilirubin level: A retrospective cohort study.
Han HS; Park CM; Lee DS; Sinn DH; Gil E
PLoS One; 2021; 16(8):e0255230. PubMed ID: 34351969
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal Blood Purification with CytoSorb in 359 Critically Ill Patients.
Pieri M; Bonizzoni MA; Belletti A; Calabrò MG; Fominskiy E; Nardelli P; Ortalda A; Scandroglio AM
Blood Purif; 2023; 52(9-10):759-767. PubMed ID: 37669640
[TBL] [Abstract][Full Text] [Related]
9. Can the cytokine adsorber CytoSorb
Scharf C; Schroeder I; Paal M; Winkels M; Irlbeck M; Zoller M; Liebchen U
Ann Intensive Care; 2021 Jul; 11(1):115. PubMed ID: 34292421
[TBL] [Abstract][Full Text] [Related]
10. International registry on the use of the CytoSorb® adsorber in ICU patients : Study protocol and preliminary results.
Friesecke S; Träger K; Schittek GA; Molnar Z; Bach F; Kogelmann K; Bogdanski R; Weyland A; Nierhaus A; Nestler F; Olboeter D; Tomescu D; Jacob D; Haake H; Grigoryev E; Nitsch M; Baumann A; Quintel M; Schott M; Kielstein JT; Meier-Hellmann A; Born F; Schumacher U; Singer M; Kellum J; Brunkhorst FM
Med Klin Intensivmed Notfmed; 2019 Nov; 114(8):699-707. PubMed ID: 28871441
[TBL] [Abstract][Full Text] [Related]
11. The application of hemoadsorption for hyperbilirubinemia and its impact on bilirubin removal kinetics in critically ill children.
Hui WF; Cheung WL; Hon KL; Ku SW
Int J Artif Organs; 2023 Apr; 46(4):241-247. PubMed ID: 36964647
[TBL] [Abstract][Full Text] [Related]
12. Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure.
Haselwanter P; Scheiner B; Balcar L; Semmler G; Riedl-Wewalka M; Schmid M; Reiberger T; Zauner C; Schneeweiss-Gleixner M
Sci Rep; 2024 May; 14(1):11309. PubMed ID: 38760460
[TBL] [Abstract][Full Text] [Related]
13. Time to peak bilirubin concentration and advanced AKI were associated with increased mortality in rheumatic heart valve replacement surgery patients with severe postoperative hyperbilirubinemia: a retrospective cohort study.
Chen X; Bai M; Zhao L; Yu Y; Yue Y; Sun S; Chen X
BMC Cardiovasc Disord; 2021 Jan; 21(1):16. PubMed ID: 33407165
[TBL] [Abstract][Full Text] [Related]
14. Significant decrease in dialysate albumin concentration during molecular adsorbent recirculating system (M.A.R.S.) therapy.
Gong D; Ji D; Ren B; Tao J; Xu B; Ronco C; Li L
Int J Artif Organs; 2008 Apr; 31(4):333-9. PubMed ID: 18432590
[TBL] [Abstract][Full Text] [Related]
15. LiFe: a liver injury score to predict outcome in critically ill patients.
Edmark C; McPhail MJW; Bell M; Whitehouse T; Wendon J; Christopher KB
Intensive Care Med; 2016 Mar; 42(3):361-369. PubMed ID: 26820880
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study.
Greimel A; Habler K; Gräfe C; Maciuga N; Brozat CI; Vogeser M; Zoller M; Happich FL; Liebchen U; Frank S; Paal M; Scharf C
Ann Intensive Care; 2023 Nov; 13(1):110. PubMed ID: 37943350
[TBL] [Abstract][Full Text] [Related]
17. Establishment of MELD-lactate clearance scoring system in predicting death risk of critically ill cirrhotic patients.
Li X; Gong M; Fu S; Zhang J; Wu S
BMC Gastroenterol; 2022 Jun; 22(1):280. PubMed ID: 35658837
[TBL] [Abstract][Full Text] [Related]
18. A matched case-control study on the effectiveness of extracorporeal cytokine adsorption in critically ill patients.
Jerman A; Gubenšek J; Berden J; Peršič V
Sci Rep; 2023 Aug; 13(1):13464. PubMed ID: 37596304
[TBL] [Abstract][Full Text] [Related]
19. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.
Alharthy A; Faqihi F; Memish ZA; Balhamar A; Nasim N; Shahzad A; Tamim H; Alqahtani SA; Brindley PG; Karakitsos D
Artif Organs; 2021 May; 45(5):E101-E112. PubMed ID: 33190288
[TBL] [Abstract][Full Text] [Related]
20. Comparison of albumin dialysis devices molecular adsorbent recirculating system and ADVanced Organ Support system in critically ill patients with liver failure-A retrospective analysis.
Falkensteiner C; Kortgen A; Leonhardt J; Bauer M; Sponholz C
Ther Apher Dial; 2021 Apr; 25(2):225-236. PubMed ID: 32515160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
